Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
380
-
Total 13F shares, excl. options
-
19.2M
-
Shares change
-
+18K
-
Total reported value, excl. options
-
$4.63B
-
Value change
-
+$3.47M
-
Put/Call ratio
-
3.32
-
Number of buys
-
162
-
Number of sells
-
-265
-
Price
-
$241.32
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q2 2025
487 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q2 2025.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 380 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.2M shares
.
Largest 10 shareholders include First Eagle Investment Management, LLC (2.52M shares), VANGUARD GROUP INC (1.85M shares), BlackRock, Inc. (1.76M shares), DIMENSIONAL FUND ADVISORS LP (1M shares), Veritas Asset Management LLP (863K shares), ARIEL INVESTMENTS, LLC (819K shares), EARNEST PARTNERS LLC (606K shares), STATE STREET CORP (584K shares), BANK OF AMERICA CORP /DE/ (452K shares), and First Pacific Advisors, LP (387K shares).
This table shows the top 380 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.